Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125522252 | 12552225 | 2 | F | 20130509 | 20160802 | 20160713 | 20160805 | EXP | PHHO2013IE017576 | NOVARTIS | 44.74 | YR | F | Y | 0.00000 | 20160805 | MD | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125522252 | 12552225 | 1 | PS | TYKERB | LAPATINIB DITOSYLATE | 1 | Oral | Y | 22059 | TABLET | |||||||||
| 125522252 | 12552225 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 8 MG/KG, UNK | 0 | 8 | MG/KG | ||||||||
| 125522252 | 12552225 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 6 IU, UNK | 0 | 6 | IU | ||||||||
| 125522252 | 12552225 | 4 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 75 MG/M2, UNK | 0 | 75 | MG/M**2 | ||||||||
| 125522252 | 12552225 | 5 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 125522252 | 12552225 | 6 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1500 MG, | U | 0 | 1500 | MG | |||||||
| 125522252 | 12552225 | 7 | C | LOPERAMIDE | LOPERAMIDE | 1 | Oral | 4 MG, | U | 0 | 4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125522252 | 12552225 | 1 | Breast cancer |
| 125522252 | 12552225 | 2 | Breast cancer |
| 125522252 | 12552225 | 3 | Breast cancer |
| 125522252 | 12552225 | 4 | Breast cancer |
| 125522252 | 12552225 | 5 | Prophylaxis |
| 125522252 | 12552225 | 6 | Prophylaxis |
| 125522252 | 12552225 | 7 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125522252 | 12552225 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125522252 | 12552225 | Alanine aminotransferase increased | |
| 125522252 | 12552225 | Aspartate aminotransferase increased | |
| 125522252 | 12552225 | Enteritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125522252 | 12552225 | 1 | 20130503 | 20130508 | 0 | |
| 125522252 | 12552225 | 2 | 20130503 | 0 | ||
| 125522252 | 12552225 | 3 | 20130503 | 0 | ||
| 125522252 | 12552225 | 4 | 20130503 | 0 | ||
| 125522252 | 12552225 | 5 | 20130509 | 0 | ||
| 125522252 | 12552225 | 6 | 20130509 | 0 | ||
| 125522252 | 12552225 | 7 | 20130503 | 20130508 | 0 |